Evidence map›Paper›PMID 34208969›Full record

ArticleJournal of clinical medicine2021

A Prospective Multicenter Study of "Inside Stents" for Biliary Stricture: Multicenter Evolving Inside Stent Registry (MEISteR).

Hirofumi Kogure, Hironari Kato, Kazumichi Kawakubo, Hirotoshi Ishiwatari, Akio Katanuma, Yoshinobu Okabe, Toru Ueki, Tesshin Ban, Keiji Hanada, Kazuya Sugimori and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 11 institutions in 1 country.

Hirofumi KogureDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.ORCID 0000-0002-2355-7309
Hironari KatoDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Kazumichi KawakuboDepartment of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Sapporo 060-8648, Japan.ORCID 0000-0002-8979-9474
Hirotoshi IshiwatariDepartment of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
Akio KatanumaCenter for Gastroenterology, Teine-Keijinkai Hospital, Sapporo 006-0811, Japan.
Yoshinobu OkabeDivision of Gastroenterology, Department of Medicine, Kurume University of Medicine, Kurume 830-0011, Japan.
Toru UekiDepartment of Internal Medicine, Fukuyama City Hospital, Fukuyama 721-8511, Japan.
Tesshin BanDepartment of Gastroenterology, Nagoya Daini Red Cross Hospital, Nagoya 466-8650, Japan.
Keiji HanadaDepartment of Gastroenterology, Onomichi General Hospital, Onomichi 722-8508, Japan.ORCID 0000-0003-3196-8551
Kazuya SugimoriDivision of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama 232-0024, Japan.
Yousuke NakaiDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Hiroyuki IsayamaDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.ORCID 0000-0002-3308-9326
The University of Tokyo · JPFukuyama City Hospital · JPHokkaido University · JPJapanese Red Cross Nagoya Daini Hospital · JPJuntendo University · JPKurume University · JPOkayama University · JPOnomichi General Hospital · JPSapporo Medical University · JPTeine Keijinkai Hospital · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndoscopic biliary stent placement is the standard of care for biliary strictures, but stents across the papilla are prone to duodenobiliary reflux, which can cause stent occlusion. Preliminary studies of "inside stents" placed above the papilla showed encouraging outcomes, but prospective data with a large cohort were not reported.

methodsThis was a prospective multicenter registry of commercially available inside stents for benign and malignant biliary strictures. Primary endpoint was recurrent biliary obstruction (RBO). Secondary endpoints were technical success of stent placement and removal, adverse events, and stricture resolution.

resultsA total of 209 inside stents were placed in 132 (51 benign and 81 malignant) cases with biliary strictures in 10 Japanese centers. During the follow-up period of 8.4 months, RBO was observed in 19% of benign strictures. The RBO rate was 49% in malignant strictures, with the median time to RBO of 4.7 months. Technical success rates of stent placement and removal were both 100%. The adverse event rate was 8%.

conclusionThis prospective multicenter study demonstrated that inside stents above the papilla were feasible in malignant and benign biliary strictures, but a randomized controlled trial is warranted to confirm its superiority to conventional stents across the papilla.

Indexed as

biliary strictureendoscopic biliary stent placementinside stent

Identifiers

PMID34208969
PMCPMC8268973
OpenAlexW3173430273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.